A detailed history of Concurrent Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 12,685 shares of AZN stock, worth $954,165. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,685
Previous 9,088 39.58%
Holding current value
$954,165
Previous $709 Million 39.44%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$76.67 - $87.62 $275,781 - $315,169
3,597 Added 39.58%
12,685 $988 Million
Q2 2024

Jul 30, 2024

BUY
$66.81 - $80.83 $373,467 - $451,839
5,590 Added 159.81%
9,088 $709 Million
Q1 2024

May 07, 2024

BUY
$61.03 - $69.57 $32,040 - $36,524
525 Added 17.66%
3,498 $237 Million
Q4 2023

Apr 15, 2024

BUY
$61.89 - $69.28 $183,998 - $205,969
2,973 New
2,973 $200 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $233B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.